The cannabis plant has had a troubled history. It was used for medical purposes with several clinical indications in various ancient civilizations such as Egyptian and Chinese. At the beginning of last century there were restrictions to its use due to the psychoactive effect of some subspecies of this plant.

In 1940, CBD was isolated from the remaining components of the plant.

In the 1980s, some new receptors were discovered in the human body to which some cannabinoids attached themselves. These receptors belonged to a system that allowed body homeostasis by regulating several other systems such as the nervous system and the immune system.

With these findings, coupled with the fact that CBD does not cause euphoria disorders and an increasing number of reports of people showing benefits from the use of CBD, there has begun to be an interest in the scientific community for further study.

Nowadays, there are already some clinical trials on various diseases or symptoms, such as pain, anxiety, insomnia, epilepsy, Alzheimer, among others.

Since January 2019, the European Union has considered CBD as a novel food. The World Health Organization reports that cannabidiol has therapeutic potential and is safe.

This openness of institutional entities to CBD allows scientific research to advance more quickly in this area, and more people can have access to the benefits that CBD brings.